Medical Business Units Join Together for
Comprehensive & Complementary Clinical Solutions
Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”), today
announced the rebranding of its Medical segment as the Mirion
Medical group, comprised of the organization’s healthcare-focused
Dosimetry Services, Sun Nuclear, CIRS, Biodex, and Capintec
business units. The establishment of the Mirion Medical group
reinforces the Mirion commitment to leveraging its expertise in
ionizing radiation for healthcare applications.
“Our keystone focus on ionizing radiation has broad
applicability in the healthcare field, and our solutions protect
practitioners and improve outcomes for patients. Given the
expanding scope of our work and commercial reach, it is natural to
bring our healthcare businesses together under a unified banner,”
notes Thomas Logan, CEO of Mirion Technologies and acting Mirion
Medical President.
The Mirion investment in healthcare began in late 2003 with the
Dosimetry Services division. Mirion Dosimetry Services betters the
human condition by providing ongoing monitoring of radiation
exposure for those who are occupationally exposed thereby removing
the worry of radiation in their daily routines. The well-known
Instadose®+ wireless dosimetry platform offers on-demand dose reads
via mobile device or PC, automatic calendar-set dose reads, online
badge reassignments, and high dose email alerts that keeps
clinicians aware of their radiation risk with immediate dose
results available at their fingertips.
Sun Nuclear, a key brand within the Mirion Medical group, offers
Radiation Therapy and Diagnostic Imaging solutions and services
that better the human condition by enhancing the checks and
balances that keep cancer treatment safe, effective, and
ever-improving. Through nearly 40 years of service, Sun Nuclear has
innovated proven Quality Management solutions and is stronger than
ever, with a continued commitment to easing technology adoption,
optimizing Quality Management, and ensuring Patient Safety. Sun
Nuclear has become strategically aligned with CIRS, leaders in
tissue simulation technology, anthropomorphic phantoms, and
comprehensive testing and verification solutions. With the
introduction of the Mirion Medical brand, CIRS solutions will
integrate into the Sun Nuclear brand.
In the Nuclear Medicine space, Biodex and Capintec teams now
operate as one, under the Capintec name. Recognized as a leader in
the development, manufacturing and marketing of state-of-the-art
radiation measuring and monitoring instrumentation, Capintec seeks
to better the human condition by protecting people from exposure
during potentially life-saving diagnosis and therapy. From dose
preparation to patient administration, Capintec nuclear medicine
and molecular imaging solutions enhance safety and efficiency for
technologists and physicists throughout the care continuum. The
Biodex brand remains focused on Physical Medicine and Medical
Imaging, providing science-based solutions for rehabilitation
exercise and injury recovery, as well as advanced surgical and
ultrasound tables to support a quality imaging experience for
practitioners and patients.
“Mirion Medical represents the science of better. We’re
committed to enhancing the delivery and ensuring the safety of
healthcare treatments to truly better the human condition. For
practitioners, our advanced technologies streamline workflows and
reduce risk, while their patients benefit from a safer, more
efficient healthcare experience. As a unified group, Mirion Medical
innovates with complementary solutions in the fields of Medical
Imaging, Radiation Therapy, Occupational Dosimetry, and Physical
Medicine,” notes Mr. Logan.
The Mirion Medical group will take on a family brand identity
that carries across all business units in the group. The new logos
will feature the Mirion “M”, symbolizing the strength of this group
as part of the Mirion Technologies family. This refreshed brand
will become visible on all Mirion Medical group digital properties
and at select upcoming events. Learn more about the Mirion Medical
group at mirion.com/medical.
Mirion Technologies continues to be a leading provider of
detection, measurement, analysis and monitoring solutions for the
nuclear, defense, medical and research end markets. The
establishment of Mirion Medical will not change how Mirion
Technologies reports financial performance externally, or how the
Industrial group operates.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 21E of the Securities Exchange Act of 1934.
Words such as “anticipate,” “believe,” “continue,” “could,”
“estimate,” “expect,” “hope,” “intend,” “may,” “might,” “should,”
“would,” “will,” “understand” and similar words are intended to
identify forward looking statements. These forward-looking
statements include but are not limited to, statements regarding the
Mirion products, technology, and market positioning. There are a
significant number of factors that could cause actual results to
differ materially from statements made in this press release,
including those described under the captions “Risk Factors” and
“Management’s Discussion and Analysis of Financial Condition and
Results of Operations” set forth in filings and reports we make
from time to time with the Securities and Exchange Commission,
including our most recent Annual Report on Form 10-K and Quarterly
Report on Form 10-Q.
You should not rely on these forward-looking statements, as
actual outcomes and results may differ materially from those
contemplated by these forward-looking statements as a result of
such risks and uncertainties. All forward-looking statements in
this press release are based on information available to us as of
the date hereof, and we do not assume any obligation to update the
forward-looking statements provided to reflect events that occur or
circumstances that exist after the date on which they were
made.
About Mirion
Mirion Technologies is a leading provider of detection,
measurement, analysis and monitoring solutions to the nuclear,
defense, medical and research end markets. The organization aims to
harness its unrivaled knowledge of ionizing radiation for the
greater good of humanity. Headquartered in Atlanta (GA – USA),
Mirion employs around 2,600 people and operates in 13 countries.
For more information, and for the latest news and content from
Mirion, visit Mirion.com.
Sun Nuclear, CIRS, Capintec, Biodex, and Instadose are
registered trademarks or trademarks of Mirion Technologies, Inc.
and/or its affiliates in the United States and/or other
countries.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220705005558/en/
For investor inquiries: Jerry Estes ir@mirion.com
For media inquiries: Matthew Maddox
mmaddox@mirion.com
Mirion Technologies (NYSE:MIR)
Historical Stock Chart
From May 2024 to Jun 2024
Mirion Technologies (NYSE:MIR)
Historical Stock Chart
From Jun 2023 to Jun 2024